Expanding the power of RNA interference
RNA carried by new nanoparticles can silence genes in many organs, could be deployed to treat cancer.
Koch Institute
Chemotherapy timing is key to success
Nanoparticles that stagger delivery of two drugs knock out aggressive tumors in mice.
Fast way to measure DNA repair
Test analyzing cells’ ability to fix different kinds of broken DNA could help doctors predict cancer risk.
Making cancer drugs better
Killian Award recipient Stephen Lippard describes his work on platinum-based chemotherapy agents.
How to build a biotech renaissance: MIT in Kendall Square
A look back at how Institute Professor Phillip Sharp, his startup Biogen, and MIT’s biotech community helped revive Kendall Square.
New view of tumors’ evolution
Sequencing of cancer cell genomes reveals potential new drug targets for an aggressive type of lung cancer.
How the immune system fights off malaria
Study reveals immune cells that are critical to combating the parasite in early stages of infection.
Ludwig Cancer Research gives $90 million to MIT
MIT is one of six institutions receiving a total of $540 million to provide reliable, long-term support for high-impact, innovative research.
Researchers unlock a new means of growing intestinal stem cells
Studying these cells could lead to new treatments for diseases ranging from gastrointestinal disease to diabetes.
Five from MIT named AAAS fellows
The professors were recognized by their peers for their efforts to advance science or its applications.
Biologists ID new cancer weakness
Drugs that block new target gene could make many tumors more vulnerable to chemotherapy.
Better batteries through biology?
MIT researchers find a way to boost lithium-air battery performance, with the help of modified viruses.
Finding blood clots before they wreak havoc
Simple urine test developed by MIT engineers uses nanotechnology to detect dangerous blood clotting.